Taylor Wealth Management Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Taylor Wealth Management Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$416K	Sell	1,477 -1	-0.1%	-$268	0.24%	47
2022 Q1	$386K	Buy	1,478 +5	+0.3%	+$1.19K	0.16%	52
2021 Q4	$323K	Sell	1,473 -250	-15%	-$48.6K	0.11%	57
2021 Q3	$313K	Buy	1,723 +240	+16%	+$46.9K	0.11%	59
2021 Q2	$299K	Buy	1,483 +90	+6%	+$18.8K	0.11%	57
2021 Q1	$299K	Buy	1,393 +30	+2%	+$6.59K	0.11%	59
2020 Q4	$322K	Buy	1,363 +311	+30%	+$71.4K	0.12%	52
2020 Q3	$286K	Buy	+1,052	New	+$290K	0.13%	46
2019 Q1	–	Sell	-350	Closed	-$58K	–	112
2018 Q4	$58K	Hold	350	–	–	0.03%	58
2018 Q3	$67K	Sell	350 -500	-59%	-$89K	0.03%	69
2018 Q2	$144K	Hold	850	–	–	0.06%	55
2018 Q1	$139K	Hold	850	–	–	0.07%	54
2017 Q4	$127K	Sell	850 -100	-11%	-$14.8K	0.05%	72
2017 Q3	$144K	Hold	950	–	–	0.06%	72
2017 Q2	$122K	Hold	950	–	–	0.06%	73
2017 Q1	$104K	Sell	950 -6,341	-87%	-$558K	0.05%	79
2016 Q4	$537K	Sell	7,291 -2,770	-28%	-$225K	0.25%	42
2016 Q3	$877K	Sell	10,061 -27,648	-73%	-$2.61M	0.39%	39
2016 Q2	$3.24M	Sell	37,709 -7,037	-16%	-$608K	1.3%	33
2016 Q1	$3.56M	Sell	44,746 -885	-2%	-$80.1K	1.68%	28
2015 Q4	$5.74M	Buy	45,631 +21,701	+91%	+$2.62M	2.47%	16
2015 Q3	$2.49M	Buy	+23,930	New	+$3.07M	1.2%	29

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Taylor Wealth Management Partners's VRTX Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 0.07% in Q2 2022, selling an estimated $268 and leaving 1,477 shares worth $416K. The position accounts for 0.24% of the portfolio, ranked #47.

Taylor Wealth Management Partners first reported a position in VRTX in Q3 2015 and has held it in 22 quarters since. The position peaked at $5.74M in Q4 2015. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

Taylor Wealth Management Partners held 1,477 shares of Vertex Pharmaceuticals worth $416K as of Q2 2022.
Taylor Wealth Management Partners sold 1 Vertex Pharmaceuticals share in Q2 2022, an estimated $268.
Vertex Pharmaceuticals made up 0.24% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #47 holding.
Taylor Wealth Management Partners first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 22 quarters since.
Taylor Wealth Management Partners's Vertex Pharmaceuticals position peaked at $5.74M in Q4 2015.
1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.